CJC-1295 DAC Peptide
CJC-1295 DAC is supplied strictly for laboratory research and in-vitro experimentation.
It is not intended for human or veterinary use, consumption, diagnosis, treatment, or prevention
of any disease.
Buy CJC-1295 DAC | Product Description
CJC-1295 DAC is a synthetic analog of growth hormone-releasing hormone (GHRH)
designed as a research peptide for studying growth hormone pathway signaling.
The compound contains a drug affinity complex (DAC) modification intended to
investigate peptide stability and extended interaction profiles in controlled
experimental environments.
Researchers study CJC-1295 DAC as a modified GHRH analog consisting of the first
29 amino acids of GHRH with structural modifications designed to examine receptor
binding characteristics, peptide stability, and growth hormone-related signaling
mechanisms.
CJC-1295 DAC Specifications
| Product Name | CJC-1295 with DAC |
| Classification | Research Peptide |
| Molecular Formula | C152H252N44O42 |
| Molecular Weight | 3367.954 g/mol |
| Sequence | H-Tyr-D-Ala-Asp-Ala-Ile-Phe-Thr-Gln-Ser-Tyr-Arg-Lys-Val-Leu-Ala-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Leu-Ser-Arg-Lys(Mal)-NH2 |
| Form | Lyophilized peptide powder |
| Storage | Store according to laboratory handling guidelines |
Buy CJC-1295 DAC | Research Applications
CJC-1295 DAC is investigated in controlled laboratory settings involving:
- GHRH receptor interaction studies
- Peptide-receptor binding research
- Growth hormone pathway investigations
- Peptide stability and pharmacokinetic research
- Signal transduction analysis
- Experimental endocrine pathway modeling
Mechanism of Research Interest
Research models have examined CJC-1295 DAC for its interaction with growth
hormone-releasing hormone receptors. These studies investigate receptor-mediated
signaling pathways involving intracellular messengers and downstream molecular
responses associated with growth hormone regulation.
The DAC modification is studied for its influence on peptide behavior, including
interactions with plasma proteins and extended stability characteristics compared
with shorter GHRH analogs.
Key Research Areas
Growth Hormone Signaling Studies
Researchers use CJC-1295 DAC as a molecular tool to investigate GHRH receptor
activation and growth hormone pathway regulation in experimental models.
Peptide Stability Research
The DAC modification provides a framework for studying structural changes,
peptide stability, and receptor interaction profiles.
Endocrine Pathway Analysis
Laboratory studies explore interactions within growth hormone and IGF-related
signaling pathways under controlled research conditions.
Handling & Storage Information
- Handle only in appropriate laboratory environments.
- Use suitable protective equipment during handling.
- Protect material from excessive heat, moisture, and contamination.
- Follow institutional research safety procedures.
Frequently Asked Questions
What is CJC-1295 DAC?
CJC-1295 DAC is a synthetic GHRH analog studied as a research compound for
investigating peptide-receptor interactions and growth hormone signaling pathways.
Is CJC-1295 DAC approved for human use?
No. This product is intended strictly for laboratory research purposes and is not
approved as a medication or supplement.
How should CJC-1295 DAC be stored?
Storage conditions should follow laboratory requirements and product-specific
handling documentation.
Research Compliance Statement
This product is intended exclusively for qualified researchers and laboratory use.
It is not manufactured, sold, or represented as a product for human or animal
administration.
Explore
Buy CJC-1295 DAC
and related growth hormone research products including
Buy GHRP-6,
Buy HGH,
Buy IGF-1 LR3,
and
MK-677 for Sale | Buy MK-677.
Visit our
Growth Hormones & Peptides
category to explore additional peptide-related research products.
Reviews
There are no reviews yet.